These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22505514)

  • 1. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.
    Avgeris M; Mavridis K; Scorilas A
    Biol Chem; 2012 Apr; 393(5):301-17. PubMed ID: 22505514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-related peptidases in cancers of gastrointestinal tract: an inside view of their role and clinical significance.
    Linardoutsos D; Gazouli M; Machairas A; Bramis I; Zografos GC
    J BUON; 2014; 19(1):53-9. PubMed ID: 24659643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
    Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
    Avgeris M; Mavridis K; Scorilas A
    Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
    Scorilas A; Mavridis K
    Expert Rev Mol Diagn; 2014 Jul; 14(6):713-22. PubMed ID: 24927162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer.
    Fuhrman-Luck RA; Silva ML; Dong Y; Irving-Rodgers H; Stoll T; Hastie ML; Loessner D; Gorman JJ; Clements JA
    Proteomics Clin Appl; 2014 Jun; 8(5-6):403-15. PubMed ID: 24535680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers.
    Kontos CK; Scorilas A
    Clin Chem Lab Med; 2012 Nov; 50(11):1877-91. PubMed ID: 23093268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.
    Dorn J; Bayani J; Yousef GM; Yang F; Magdolen V; Kiechle M; Diamandis EP; Schmitt M
    Thromb Haemost; 2013 Sep; 110(3):408-22. PubMed ID: 23765253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.
    Figueroa CD; Molina L; Bhoola KD; Ehrenfeld P
    Biol Chem; 2018 Sep; 399(9):937-957. PubMed ID: 29885274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.
    Pasic MD; Olkhov E; Bapat B; Yousef GM
    Biol Chem; 2012 Apr; 393(5):319-30. PubMed ID: 22505515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: mechanistic and clinical aspects.
    Kontos CK; Mavridis K; Talieri M; Scorilas A
    Thromb Haemost; 2013 Sep; 110(3):450-7. PubMed ID: 23446315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human tissue kallikreins: the cancer biomarker family.
    Paliouras M; Borgono C; Diamandis EP
    Cancer Lett; 2007 Apr; 249(1):61-79. PubMed ID: 17275179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
    Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH
    Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting kallikrein-related peptidases in prostate cancer.
    Mavridis K; Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2014 Apr; 18(4):365-83. PubMed ID: 24571737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
    Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.
    Mavridis K; Scorilas A
    Future Oncol; 2010 Feb; 6(2):269-85. PubMed ID: 20146586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.
    Veveris-Lowe TL; Kruger SJ; Walsh T; Gardiner RA; Clements JA
    Semin Thromb Hemost; 2007 Feb; 33(1):87-99. PubMed ID: 17253195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.
    Cereda V; Formica V; Menghi A; Pellicori S; Roselli M
    Expert Opin Investig Drugs; 2015; 24(7):929-47. PubMed ID: 25858813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interdependence of kallikrein-related peptidases in proteolytic networks.
    Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V
    Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.
    Pampalakis G; Sotiropoulou G
    Biochim Biophys Acta; 2007 Sep; 1776(1):22-31. PubMed ID: 17629406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.